FIELD: medicine.
SUBSTANCE: invention refers to medicine and aims at prediction of floating deep venous thrombosis in the inferior vena cava. Clinical laboratory and instrumental methods of examination are applied, and if observing the signs related to deep venous thrombosis, molecular genetic analysis of the first-type plasminogen activator inhibitor (PAI-1) gene is performed additionally. If a polymorphous variant 675 4G/4G of the PAI-1 gene, the presence of the thrombus flotation is predicted.
EFFECT: invention provides the effective method for prediction of the thrombus flotation in the inferior vena cava and enables using the targeted drug-induced correction of fibrinolysis.
2 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PROGNOSIS OF SEVERITY OF DISSEMINATED BLOOD COAGULATION ACUTE SYNDROME USING INTRAVASCULAR GENETIC MONITORING | 2005 |
|
RU2303262C2 |
| METHOD FOR DIAGNOSING THROMBINEMIA IN PATIENTS WITH COVID-19 INFECTION | 2022 |
|
RU2794035C1 |
| METHOD OF PERSONALIZED PREDICTION OF DEVELOPMENT OF THROMBOEMBOLIC COMPLICATIONS IN URGENT ABDOMINAL SURGERY | 2023 |
|
RU2807903C1 |
| METHOD FOR PREDICTION OF CRYOGLOBULINEMIC VASCULITIS DEVELOPMENT IN PATIENTS WITH CHRONIC HEPATITIS C | 2016 |
|
RU2642626C1 |
| METHOD FOR EARLY PREDICTION OF CHORION AND PLACENTA DETACHMENT ON BASIS OF DETECTING GENE POLYMORPHISM OF TYPE 1 PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) | 2012 |
|
RU2494400C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PROTHROMBOTIC CHANGES IN ADOLESCENTS WITH ESSENTIAL ARTERIAL HYPERTENSION | 2013 |
|
RU2514887C1 |
| METHOD FOR PERICONCEPTIONAL PREDICTION OF RECURRENT EARLY REPRODUCTIVE LOSSES AND PRIMARY PLACENTAL INSUFFICIENCY | 2019 |
|
RU2709246C1 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF ARTERIAL AND VENOUS THROMBOSIS IN NEWBORNS | 2023 |
|
RU2818815C1 |
| METHOD FOR THROMBOEMBOLIC COMPLICATIONS PREDICTION | 2016 |
|
RU2621298C1 |
| METHOD OF DIAGNOSING OCCLUSIVE AFFECTION OF VESSELS IN PATIENTS WITH CARDIOVASCULAR DISEASES | 2013 |
|
RU2557916C1 |
